|
|
Volumn 36, Issue 7, 2004, Pages 2110-2112
|
|
The role of anti-IL-2 receptor in high-risk kidney transplant patients
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BASILIXIMAB;
CYCLOSPORIN A;
DACLIZUMAB;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
STEROID;
THYMOCYTE ANTIBODY;
ACUTE GRAFT REJECTION;
CONFERENCE PAPER;
CONTROLLED STUDY;
GRAFT FAILURE;
GRAFT SURVIVAL;
HIGH RISK PATIENT;
HLA MATCHING;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KAPLAN MEIER METHOD;
KIDNEY DONOR;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
MAJOR CLINICAL STUDY;
MORTALITY;
PRIORITY JOURNAL;
SURVIVAL RATE;
ANTIBODIES, MONOCLONAL;
DISEASE-FREE SURVIVAL;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY TESTING;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
MALE;
RECEPTORS, INTERLEUKIN-2;
RECOMBINANT FUSION PROTEINS;
REOPERATION;
RETROSPECTIVE STUDIES;
SPOUSES;
SURVIVAL ANALYSIS;
THAILAND;
TIME FACTORS;
|
|
EID: 7044249273
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.08.088 Document Type: Conference Paper |
|
Times cited : (12)
|
|
References (11)
|
